XML 46 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 1,700 $ 1,639
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion (including amortization of nuclear fuel) 2,923 2,753
Equity in (earnings) losses of unconsolidated affiliates (61) 8
Equity component of AFUDC (99) (83)
Impairment of assets and other charges 206 131
Deferred income taxes 67 119
Payments for asset retirement obligations (255) (263)
Provision for rate refunds (65) (13)
(Increase) decrease in    
Net realized and unrealized mark-to-market and hedging transactions 351 15
Receivables (180) 85
Inventory (12) 153
Other current assets (1,144) (297)
Increase (decrease) in    
Accounts payable 408 (297)
Taxes accrued (49) 219
Other current liabilities 99 (326)
Other assets 55 77
Other liabilities 91 (47)
Net cash provided by operating activities 4,035 3,873
CASH FLOWS FROM INVESTING ACTIVITIES    
Capital expenditures (5,117) (4,636)
Contributions to equity method investments (32) (21)
Purchases of debt and equity securities (2,184) (3,182)
Proceeds from sales and maturities of debt and equity securities 2,225 3,217
Disbursements to canceled equity method investments   (855)
Other (384) (137)
Net cash used in investing activities (5,492) (5,614)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of long-term debt 5,714 4,627
Proceeds from the issuance of common stock   5
Payments for the redemption of long-term debt (3,147) (2,002)
Proceeds from the issuance of short-term debt with original maturities greater than 90 days 30 75
Payments for the redemption of short-term debt with original maturities greater than 90 days (257) (959)
Notes payable and commercial paper 785 1,299
Contributions from noncontrolling interests 126 318
Dividends paid (1,574) (1,541)
Other (101) (72)
Net cash provided by financing activities 1,576 1,750
Net increase in cash, cash equivalents and restricted cash 119 9
Cash, cash equivalents and restricted cash at beginning of period 520 556
Cash, cash equivalents and restricted cash at end of period 639 565
Significant non-cash transactions:    
Accrued capital expenditures $ 1,264 $ 990